Labs / CDMO: development & manufacturing

Valo Therapeutics LTD
Helsinki, Finland · valotx.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Valo Therapeutics LTD develops immunotherapy platforms for cancer and infectious disease. It is based in Helsinki, Finland, and focuses on peptide-coated vector technologies for T-cell-driven anti-tumor responses.
Their website has a general contact form; we send your quote request through it.
What they offer
PeptiCRAd technology
Develops a peptide-coated oncolytic adenovirus platform that combines oncolytic adenovirus and peptide vaccine approaches to target cancer cells.
PeptiENV technology
Develops an oncolytic enveloped virus platform that adsorbs tumor-specific peptides and is described for patient-specific treatment.
PeptiVAX platform
Develops a vaccine platform enhanced with disease-specific peptide targets.
PeptiCHIP
Listed as a company technology platform.
What they work on
- Modalities
- Peptide, Viral vector, Cell therapy, Vaccine
- Therapeutic areas
- oncology, infectious disease
- Sites
- Helsinki, Finland
Similar labs. Genevoyager, 3C Therapeutics, AGC Biologics, Alphalyse
Found in a contract services directory. Listing built from valotx.com. Work here? Claim this listing.